Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
2.470
0.00 (0.00%)
Mar 9, 2026, 1:52 PM EDT - Market open
Nautilus Biotechnology Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 25.73 | 31 | 28.9 | 25.95 | 21.15 | |
| Research & Development | 41.11 | 50.48 | 47.25 | 37.67 | 29.35 | |
| Operating Expenses | 66.84 | 81.48 | 76.15 | 63.62 | 50.5 | |
| Operating Income | -66.84 | -81.48 | -76.15 | -63.62 | -50.5 | |
| Interest & Investment Income | 7.87 | 10.78 | 12.55 | 5.82 | 0.33 | |
| Other Non Operating Income (Expenses) | -1.45 | -2.89 | -2.73 | -1.01 | 0.17 | |
| EBT Excluding Unusual Items | -60.42 | -73.58 | -66.33 | -58.81 | -50 | |
| Gain (Loss) on Sale of Investments | 1.42 | 2.8 | 2.66 | 0.89 | -0.18 | |
| Gain (Loss) on Sale of Assets | - | - | - | - | -0.14 | |
| Pretax Income | -59 | -70.78 | -63.68 | -57.92 | -50.32 | |
| Net Income | -59 | -70.78 | -63.68 | -57.92 | -50.32 | |
| Net Income to Common | -59 | -70.78 | -63.68 | -57.92 | -50.32 | |
| Shares Outstanding (Basic) | 126 | 125 | 125 | 125 | 84 | |
| Shares Outstanding (Diluted) | 126 | 125 | 125 | 125 | 84 | |
| Shares Change (YoY) | 0.66% | 0.41% | 0.27% | 47.51% | 190.36% | |
| EPS (Basic) | -0.47 | -0.56 | -0.51 | -0.46 | -0.60 | |
| EPS (Diluted) | -0.47 | -0.56 | -0.51 | -0.46 | -0.60 | |
| Free Cash Flow | -51.97 | -62.03 | -54.15 | -48.13 | -41.51 | |
| Free Cash Flow Per Share | -0.41 | -0.49 | -0.43 | -0.39 | -0.49 | |
| EBITDA | -65.08 | -79.42 | -74.3 | -62.4 | -49.48 | |
| D&A For EBITDA | 1.75 | 2.06 | 1.85 | 1.22 | 1.02 | |
| EBIT | -66.84 | -81.48 | -76.15 | -63.62 | -50.5 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.